Protalix Biotherapeutics Inc (PLX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Protalix Biotherapeutics inc   (NYSEAMER: PLX)
 

Protalix Biotherapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Protalix Biotherapeutics Inc 's inventory turnover ratio sequentially decreased to 0.91 in the second quarter 2026, unsurprisingly, as the Protalix Biotherapeutics Inc markets continue to deteriorate, and PLX's faces growing challenges to bring down its inventories. Protalix Biotherapeutics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 401 days, from 392 days, in the Mar 31 2026 quarter.

Within Healthcare sector 323 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1469 in the first quarter 2026, to 1835.

PLX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Protalix Biotherapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PLX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 52.82 % 56.23 % 21.12 % 23.58 % 1.99 %
Y / Y Cost of Sales Growth 32.23 % -49.55 % 18.86 % -0.61 % -37.92 %
Inventory Turnover Ratio (TTM) 0.91 0.93 1.23 1.26 1.33
PLX's Total Ranking # 1835 # 1469 # 1417 # 1114 # 1340
Average inventory processing period 403 392 296 289 274
Seq. Inventory Growth 5.97 % 18.44 % 21.05 % 0.59 % 8.33 %
Seq. Cost of Sales Growth 88.08 % -10.65 % -44.51 % 41.81 % -28.24 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 23
Healthcare Sector # 324
Overall Market # 1835

Inventory Turnover Ratio Statistics
High Average Low
9.65 1.67 0.76
(Jun 30 2012)   (Dec 31 2013)



PLX Company Profile >> Back to PLX Efficiency Comparisons >> Compare PLX Inventory Turnover Ratio to its Competitors

Financial Statements
Protalix Biotherapeutics Inc 's Inventories $ 32 Millions Visit PLX's Balance sheet
Protalix Biotherapeutics Inc 's Cost of Revenues TTM $ 25 Millions Visit PLX's Income Statement
What are PLX's Sales? Visit PLX's Sales by Segment

Other Inventory Turnover Ratios
Protalix Biotherapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PLX's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PLX's Competitors
Inventory Turnover Ratio for PLX's Suppliers
Inventory Turnover Ratio for PLX's Customers

You may also want to know
PLX's Sales Growth Rates PLX's Pe Price to earnings ratio PLX's Receivables Turnover Ratio PLX's Stock Quote
PLX's Net Income Growth Rates PLX's Ps Price to Sales ratio PLX's Sales per Employee PLX's Asset Turnover Ratio
PLX's Net Margin PLX's Pb Price to Book ratio PLX's Financial Strength Ratios PLX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Dariohealth Corp   2.10 $ 8.985  Millions$ 4  Millions
Bio techne Corp  2.10 $ 414.798  Millions$ 197  Millions
Yunhong Green Cti Ltd   2.09 $ 17.362  Millions$ 8  Millions
Repligen Corp  2.08 $ 362.434  Millions$ 174  Millions
Anteris Technologies Global Corp   2.08 $ 0.561  Millions$ 0  Millions
Lifevantage Corp  2.08 $ 39.334  Millions$ 19  Millions
Organon and Co   2.06 $ 2,899.000  Millions$ 1,405  Millions
Glaukos Corp  2.06 $ 128.016  Millions$ 62  Millions
Orasure Technologies Inc  2.05 $ 64.117  Millions$ 31  Millions
Phibro Animal Health Corporation  2.02 $ 1,004.346  Millions$ 498  Millions
Waters Corporation  2.00 $ 2,008.498  Millions$ 1,005  Millions
Retractable Technologies Inc  1.94 $ 33.979  Millions$ 17  Millions
Intuitive Surgical Inc   1.94 $ 3,676.900  Millions$ 1,899  Millions
Lifeloc Technologies Inc   1.93 $ 5.381  Millions$ 3  Millions
Accuray Incorporated  1.93 $ 290.064  Millions$ 150  Millions
Immucell Corporation  1.89 $ 17.409  Millions$ 9  Millions
Safe Pro Group Inc   1.88 $ 1.089  Millions$ 1  Millions
Rigel Pharmaceuticals Inc  1.88 $ 23.839  Millions$ 13  Millions
Sunshine Biopharma Inc   1.87 $ 24.637  Millions$ 13  Millions
Seastar Medical Holding Corp  1.78 $ 0.126  Millions$ 0  Millions
Alpha Pro Tech Ltd   1.76 $ 38.696  Millions$ 22  Millions
Tenon Medical Inc   1.76 $ 1.763  Millions$ 1  Millions
Iradimed Corporation  1.76 $ 20.839  Millions$ 12  Millions
Utah Medical Products Inc  1.75 $ 14.771  Millions$ 8  Millions
Elutia Inc   1.75 $ 4.337  Millions$ 2  Millions
Axsome Therapeutics Inc   1.73 $ 52.530  Millions$ 30  Millions
Vycor Medical Inc   1.72 $ 0.301  Millions$ 0  Millions
Quanterix Corporation  1.69 $ 87.760  Millions$ 52  Millions
Conmed Corporation  1.68 $ 606.349  Millions$ 362  Millions
Stryker Corp  1.67 $ 9,049.000  Millions$ 5,405  Millions

Date modified: 2026-09-04T10:37:32+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.